Literature DB >> 21477046

Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.

Jermaine D Jones1, Suzanne K Vosburg, Jeanne M Manubay, Sandra D Comer.   

Abstract

This pilot study sought to characterize typical nonmedical oxycodone use in the New York Metropolitan area. Accordingly, a clinical interview was administered to 25 intranasal (IN) and 25 intravenous (IV) oxycodone abusers to capture demographics and patterns of use within the region. IN and IV abusers shared a number of similar characteristics including age, proportion of men and women, criminal history, drug use history, and current recreational drug use. However, the two populations also differed in a number of aspects. IV oxycodone users had lower rates of employment, earlier onset of illicit drug use, and more current heroin use. Although IN users reported somewhat more frequent use of oxycodone weekly, IV users were more likely to supplement their oxycodone use with other opioid drugs, most notably heroin. Additional research is needed to confirm these observed differences, yet these data may assist treatment efforts by providing information to guide targeted treatment and population-specific interventions. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21477046      PMCID: PMC3320719          DOI: 10.1111/j.1521-0391.2011.00120.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  17 in total

1.  Adolescent OxyContin Abuse.

Authors:  Debra A Katz; Lon R Hays
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-02       Impact factor: 8.829

2.  Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.

Authors:  Howard G Birnbaum; Alan G White; Jennifer L Reynolds; Paul E Greenberg; Mingliang Zhang; Sue Vallow; Jeff R Schein; Nathaniel P Katz
Journal:  Clin J Pain       Date:  2006-10       Impact factor: 3.442

3.  Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

Authors:  William C Becker; Lynn E Sullivan; Jeanette M Tetrault; Rani A Desai; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

4.  Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.

Authors:  Theodore J Cicero; Hilary Surratt; James A Inciardi; Alvaro Munoz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-08       Impact factor: 2.890

5.  Prescription opioid abuse among enrollees into methadone maintenance treatment.

Authors:  Andrew Rosenblum; Mark Parrino; Sidney H Schnoll; Chunki Fong; Carleen Maxwell; Charles M Cleland; Stephen Magura; J David Haddox
Journal:  Drug Alcohol Depend       Date:  2007-03-26       Impact factor: 4.492

6.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

Authors:  James A Inciardi; Hilary L Surratt; Steven P Kurtz; Theodore J Cicero
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

7.  Internet-based survey of nonmedical prescription opioid use in the United States.

Authors:  Nathaniel Katz; Kathrine Fernandez; Alan Chang; Christine Benoit; Stephen F Butler
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

8.  Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids.

Authors:  Beth Sproule; Bruna Brands; Selina Li; Laura Catz-Biro
Journal:  Can Fam Physician       Date:  2009-01       Impact factor: 3.275

9.  Prescription opioid aberrant behaviors: a pilot study of sex differences.

Authors:  Sudie E Back; Rebecca A Payne; Angela E Waldrop; Arthur Smith; Scott Reeves; Kathleen T Brady
Journal:  Clin J Pain       Date:  2009 Jul-Aug       Impact factor: 3.442

10.  The controversy surrounding OxyContin abuse: issues and solutions.

Authors:  Sujata S Jayawant; Rajesh Balkrishnan
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

View more
  11 in total

1.  Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.

Authors:  Suzanne K Vosburg; Jermaine D Jones; Jeanne M Manubay; Judy B Ashworth; Irma H Benedek; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-06-20       Impact factor: 4.492

2.  Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication.

Authors:  P S Joshi; N Sanakkayala; L Kirkpatrick; P S Terse
Journal:  Regul Toxicol Pharmacol       Date:  2019-07-27       Impact factor: 3.271

3.  Prescription opioid use: Patient characteristics and misuse in community pharmacy.

Authors:  Gerald Cochran; Jennifer L Bacci; Thomas Ylioja; Valerie Hruschak; Sharon Miller; Amy L Seybert; Ralph Tarter
Journal:  J Am Pharm Assoc (2003)       Date:  2016-03-24

Review 4.  [Misuse of opioid analgesics. An internet analysis].

Authors:  R Krüger; W Meißner; A Zimmer
Journal:  Schmerz       Date:  2014-10       Impact factor: 1.107

5.  Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats.

Authors:  Michael D Raleigh; Megan Laudenbach; Federico Baruffaldi; Samantha J Peterson; Michaela J Roslawski; Angela K Birnbaum; F Ivy Carroll; Scott P Runyon; Scott Winston; Paul R Pentel; Marco Pravetoni
Journal:  J Pharmacol Exp Ther       Date:  2018-03-13       Impact factor: 4.030

Review 6.  The American Opioid Epidemic in Special Populations: Five Examples.

Authors:  Carlos Blanco; Mir M Ali; Aaron Beswick; Karen Drexler; Cheri Hoffman; Christopher M Jones; Tisha R A Wiley; Allan Coukell
Journal:  NAM Perspect       Date:  2020-10-26

7.  Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder.

Authors:  Fatima A Hamid; Cheryl L Marker; Michael D Raleigh; Aaron Khaimraj; Scott Winston; Paul R Pentel; Marco Pravetoni
Journal:  Vaccine       Date:  2022-04-22       Impact factor: 4.169

8.  Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.

Authors:  Jason M Wiebelhaus; D Matthew Walentiny; Patrick M Beardsley
Journal:  J Pharmacol Exp Ther       Date:  2015-10-21       Impact factor: 4.030

9.  Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.

Authors:  M D Raleigh; S J Peterson; M Laudenbach; F Baruffaldi; F I Carroll; S D Comer; H A Navarro; T L Langston; S P Runyon; S Winston; M Pravetoni; P R Pentel
Journal:  PLoS One       Date:  2017-12-01       Impact factor: 3.240

10.  Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose.

Authors:  Megan Laudenbach; Federico Baruffaldi; Christine Robinson; Philipp Carter; Davis Seelig; Carly Baehr; Marco Pravetoni
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.